Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Kiadis Pharma N.V.. (10/19/18). "Press Release: Kiadis Pharma Raises €31.2 Million in a Private Placement of 3.9 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other jurisdiction where unlawful]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Jefferies International Ltd.
  Group Leucadia (Group)
Products Product ATIR101™ (Kiadis)
  Product 2 venture capital
Index term Index term Kiadis–SEVERAL: investment, 201810 private placment €31.2m with 3.9m new shares at €8/share
Persons Person Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)
  Person 2 Hård, Karl (Kiadis 201709–201812 Head IR + Communications LEFT 1/19 before Redx Pharma + AstraZeneca)
     


   
Record changed: 2019-03-08

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Kiadis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top